Published • loading... • Updated
Weight loss drugs make it harder to get the nutrients you need—here's what to do about it
GLP-1 drugs reduce food intake by 16% to 40%, causing nutrient deficiencies in over 22% of users within a year, requiring nutrient-dense diets and protein intake.
Summary by Medical Xpress
3 Articles
3 Articles
Weight loss drugs make it harder to get the nutrients you need—here's what to do about it
Weight-loss drugs such as Ozempic, Wegovy and Mounjaro work primarily by reducing hunger. They mimic a hormone the body already produces called glucagon-like peptide-1 (GLP-1), which helps regulate appetite and feelings of fullness.
Ozempic and Wegovy: Managing Rebound Hunger and Weight Regain Risks
The Ravenous Rebound: Unmasking the Hunger Surge After Quitting GLP-1 Drugs In the realm of modern medicine, few innovations have captured public imagination quite like GLP-1 receptor agonists, the class of drugs including semaglutide (sold as Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound). These medications, originally developed for diabetes management, have surged in popularity for their potent weight-loss effects, suppressing app…
Coverage Details
Total News Sources3
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium

